Scinovex
reviewTop 1% cited

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

Journal of Leukocyte Biology · 2006 · Vol. 81(1) · pp. 28–37
Dirk FoellHelmut WittkowskiThomas VoglJohannes Roth

Abstract

Damage-associated molecular pattern (DAMP) molecules have been introduced as important proinflammatory factors of innate immunity. One example known for many years to be expressed in cells of myeloid origin are phagocytic S100 proteins, which mediate inflammatory responses and recruit inflammatory cells to sites of tissue damage. An emerging concept of pattern recognition involves the multiligand receptor for advanced glycation end products (RAGE) and Toll-like receptors (TLRs) in sensing not only pathogen-associated molecular patterns (PAMPs) but also endogenous DAMPs, including S100 proteins. S100A8, S100A9, and S100A12 are found at high concentrations in inflamed tissue, where neutrophils and monocytes belong to the most abundant cell types. They exhibit proinflammatory effects in vitro at concentrations found at sites of inflammation in vivo. Although S100A12 binds to RAGE, at least part of the proinflammatory effects of the S100A8/S100A9 complex depend upon interaction with other receptors. Because of the divergent expression patterns, the absence of S100A12 in rodents, the different interaction partners described, and the specific intracellular and extracellular effects reported for these proteins, it is important to differentiate between distinct S100 proteins rather than subsuming them with the term "S100/calgranulins." Analyzing the molecular basis of the specific effects exhibited by these proteins in greater detail bears the potential to elucidate important mechanisms of innate immunity, to establish valid biomarkers of phagocytic inflammation, and eventually to reveal novel targets for innovative anti-inflammatory therapies.

S100 Proteins and AnnexinsImmune Response and InflammationAdvanced Glycation End Products researchBiologyPhagocyteCell biologyImmunologyMolecular biologyPhagocytosis

MeSH terms

Receptor for Advanced Glycation End ProductsAnimalsArthritisAutoimmune DiseasesChemotaxisHumansInflammationS100 ProteinsPhagocytesReceptors, ImmunologicInflammatory Bowel DiseasesGlycation End Products, AdvancedModels, ImmunologicalEndothelial CellsMice
Citations
867
FWCI
13.85
field-weighted impact
References
113
Percentile
99%
vs. same field & year
Citations per year
Cited by
HMGB1 and RAGE in Inflammation and Cancer
Annual Review of Immunology · 2010 · 1,400 citations
DAMPs, PAMPs and alarmins: all we need to know about danger
Journal of Leukocyte Biology · 2006 · 2,745 citations
The Biological Basis for Cardiac Repair After Myocardial Infarction
Circulation Research · 2016 · 2,103 citations
Myeloid-derived suppressor cells as regulators of the immune system
Nature reviews. Immunology · 2009 · 6,584 citations
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
The Journal of Immunology · 2009 · 1,707 citations
Coordinated regulation of myeloid cells by tumours
Nature reviews. Immunology · 2012 · 3,481 citations
References
S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)
Biochemical and Biophysical Research Communications · 2004 · 846 citations
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Nature reviews. Immunology · 2005 · 2,484 citations
The cytokine activity of HMGB1
Journal of Leukocyte Biology · 2005 · 536 citations
A soluble protein characteristic of the nervous system
Biochemical and Biophysical Research Communications · 1965 · 1,686 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.